BioCentury
BioCentury
ARTICLE | Regulation

FDA will require data similar to BLA standard for COVID-19 emergency authorization

FDA officials vow rigorous standards for COVID-19 vaccines

By Steve Usdin, Washington Editor
September 10, 2020 11:03 PM UTC


Access this Article
Request a Trial
Purchase This Article
Log in

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)

Duke University

Verily Life Sciences LLC

Biotechnology Innovation Organization

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)

Duke University

Verily Life Sciences LLC

Biotechnology Innovation Organization

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Cookie Policy
California Privacy Rights
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
LinkedIn
Twitter
RSS
BioCentury
© 2022 BioCentury Inc. All Rights Reserved.
Copyright © 2022 BioCentury Inc. All Rights Reserved.
LinkedIn
Twitter
RSS